Correlation of prostate volume with ‘International Prostate Symptom Score’ and ‘Benign Prostatic Hyperplasia-Impact Index’ in benign prostatic hyperplasia
Abstract
Introduction: Benign prostatic Hyperplasia is a common disorder and cause of morbidity in the ageing men. The evaluation symptoms and the bother associated with it are important for management. International Prostate Symptom Score (IPSS), Quality of life (QOL) and Benign Prostatic Hyperplasia Impact Index (BII) are practiced to quantify the severity of the disease. The size of prostate gland does not correlate with lower urinary tract symptoms. Correlation among above scoring is also not clear. Aim of the study is to evaluate correlation of prostate volume with International Prostate Symptom Score, Benign Prostatic Hyperplasia Impact Index and prostate size. Methods: Prospective study. Ninety-eight patients were included. Patients were assessed preoperatively with the International Prostate Symptom Score, Benign Prostatic Hyperplasia Impact Index and prostate volumes by trans abdominal ultrasound.Results: The mean age was 66.7 ± 7.3 years (50- 84) the mean IPSS, QOL, BII and prostate volumes were 23.6 ±6.0, 5.1 ± 0.9, 7.1±2.4 and 47.5±16.63 respectively. There was positive correlation between the IPSS and BII, IPSS and QOL and BII and QOL (rs= 0.89, 0.585 and 0.530 respectively) and no correlation between IPSS and BII with prostatic weight. (rs= -0.04 and -0.07 respectively).Conclusion: Management of the benign prostate hyperplasia should be considered on the bother symptoms and not on the size of the prostate.References
Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. The Journal of urology. 1984;132(3):474-9.
2. Mebust W RRSFVA. Correlations between pathology,clinical symptoms and the course of the disease. . Proceedings of the lnternational Consultation on Benign Prostatic Hyperplasia Geneva: WHO. 1991:51-62.
3. Barry MJ, Fowler FJ, Jr., O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK. Correlation of the American Urological Association symptom index with self-administered versions of the Madsen-Iversen, Boyarsky and Maine Medical Assessment Program symptom indexes. Measurement Committee of the American Urological Association. The Journal of urology. 1992;148(5):1558-63; discussion 64.
4. Chute CG, Panser LA, Girman CJ, Oesterling JE, Guess HA, Jacobsen SJ, et al. The prevalence of prostatism: a population-based survey of urinary symptoms. J Urol. 1993;150(1):85-9.
5. Donovan JL, Kay HE, Peters TJ, Abrams P, Coast J, Matos-Ferreira A, et al. Using the ICSOoL to measure the impact of lower urinary tract symptoms on quality of life: evidence from the ICS-'BPH' Study. International Continence Society--Benign Prostatic Hyperplasia. Br J Urol. 1997;80(5):712-21.
6. Arrighi HM, Metter EJ, Guess HA, Fozzard JL. Natural history of benign prostatic hyperplasia and risk of prostatectomy. The Baltimore Longitudinal Study of Aging. Urology. 1991;38(1 Suppl):4-8.
7. Chapple CR. BHP Disease Management. Introduction and concluding remarks: Eur Urol. 1999;36 Suppl 3:1-6.
8. Kaplan SA, Te AE, Pressler LB, Olsson CA. Transition zone index as a method of assessing benign prostatic hyperplasia: correlation with symptoms, urine flow and detrusor pressure. The Journal of urology. 1995;154(5):1764-9.
9. Lee T, Seong DH, Yoon SM, Ryu JK. Prostate shape and symptom score in benign prostatic hyperplasia. Yonsei medical journal. 2001;42(5):532-8.
10. Agrawal CS, Chalise PR, Bhandari BB. Correlation of prostate volume with international prostate symptom score and quality of life in men with benign prostatic hyperplasia. Nepal Medical College journal : NMCJ. 2008;10(2):104-7.
11. Aarnink RG, Beerlage HP, De La Rosette JJ, Debruyne FM, Wijkstra H. Transrectal ultrasound of the prostate: innovations and future applications. The Journal of urology. 1998;159(5):1568-79.
12. Aarnink RG, De La Rosette JJ, Debruyne FM, Wijkstra H. Reproducibility of prostate volume measurements from transrectal ultrasonography by an automated and a manual technique. Br J Urol. 1996;78(2):219-23.
13. Roehrborn CG. Accurate determination of prostate size via digital rectal examination and transrectal ultrasound. Urology. 1998;51(4A Suppl):19-22.
14. Styles RA, Neal DE, Powell PH. Reproducibility of measurement of prostatic volume by ultrasound. Comparison of transrectal and transabdominal methods. European urology. 1988;14(4):266-9.
15. Huang Foen Chung JW, de Vries SH, Raaijmakers R, Postma R, Bosch JL, van Mastrigt R. Prostate volume ultrasonography: the influence of transabdominal versus transrectal approach, device type and operator. European urology. 2004;46(3):352-6.
16. Chen SS, Hong JG, Hsiao YJ, Chang LS. The correlation between clinical outcome and residual prostatic weight ratio after transurethral resection of the prostate for benign prostatic hyperplasia. BJU Int. 2000;85(1):79-82.
17. MC Songra RK. A study on the correlation between clinical outcome and residual prostatic weight ratio after transurethral resection of the prostate for benign prostatic hyperplasia. Indian Journal of urology. 2004;20(2):42-6.
18. AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations. J Urol. 2003;170(2 Pt 1):530-47.
19. Angalakuditi M, Seifert RF, Hayes RP, O'Leary MP, Viktrup L. Measurement properties of the benign prostatic hyperplasia impact index in tadalafil studies. Health and quality of life outcomes. 2010;8:131.
20. Barry MJ, Cockett AT, Holtgrewe HL, McConnell JD, Sihelnik SA, Winfield HN. Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia. The Journal of urology. 1993;150(2 Pt 1):351-8.
21. Boyle P, Robertson C, Mazzetta C, Keech M, Hobbs R, Fourcade R, et al. The relationship between lower urinary tract symptoms and health status: the UREPIK study. BJU international. 2003;92(6):575-80.
22. Ganpule AP, Desai MR, Desai MM, Wani KD, Bapat SD. Natural history of lower urinary tract symptoms: preliminary report from a community-based Indian study. BJU international. 2004;94(3):332-4.
23. O'Leary MP, Wei JT, Roehrborn CG, Miner M. Correlation of the International Prostate Symptom Score bother question with the Benign Prostatic Hyperplasia Impact Index in a clinical practice setting. BJU international.2008;101(12)1531-5.
2. Mebust W RRSFVA. Correlations between pathology,clinical symptoms and the course of the disease. . Proceedings of the lnternational Consultation on Benign Prostatic Hyperplasia Geneva: WHO. 1991:51-62.
3. Barry MJ, Fowler FJ, Jr., O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK. Correlation of the American Urological Association symptom index with self-administered versions of the Madsen-Iversen, Boyarsky and Maine Medical Assessment Program symptom indexes. Measurement Committee of the American Urological Association. The Journal of urology. 1992;148(5):1558-63; discussion 64.
4. Chute CG, Panser LA, Girman CJ, Oesterling JE, Guess HA, Jacobsen SJ, et al. The prevalence of prostatism: a population-based survey of urinary symptoms. J Urol. 1993;150(1):85-9.
5. Donovan JL, Kay HE, Peters TJ, Abrams P, Coast J, Matos-Ferreira A, et al. Using the ICSOoL to measure the impact of lower urinary tract symptoms on quality of life: evidence from the ICS-'BPH' Study. International Continence Society--Benign Prostatic Hyperplasia. Br J Urol. 1997;80(5):712-21.
6. Arrighi HM, Metter EJ, Guess HA, Fozzard JL. Natural history of benign prostatic hyperplasia and risk of prostatectomy. The Baltimore Longitudinal Study of Aging. Urology. 1991;38(1 Suppl):4-8.
7. Chapple CR. BHP Disease Management. Introduction and concluding remarks: Eur Urol. 1999;36 Suppl 3:1-6.
8. Kaplan SA, Te AE, Pressler LB, Olsson CA. Transition zone index as a method of assessing benign prostatic hyperplasia: correlation with symptoms, urine flow and detrusor pressure. The Journal of urology. 1995;154(5):1764-9.
9. Lee T, Seong DH, Yoon SM, Ryu JK. Prostate shape and symptom score in benign prostatic hyperplasia. Yonsei medical journal. 2001;42(5):532-8.
10. Agrawal CS, Chalise PR, Bhandari BB. Correlation of prostate volume with international prostate symptom score and quality of life in men with benign prostatic hyperplasia. Nepal Medical College journal : NMCJ. 2008;10(2):104-7.
11. Aarnink RG, Beerlage HP, De La Rosette JJ, Debruyne FM, Wijkstra H. Transrectal ultrasound of the prostate: innovations and future applications. The Journal of urology. 1998;159(5):1568-79.
12. Aarnink RG, De La Rosette JJ, Debruyne FM, Wijkstra H. Reproducibility of prostate volume measurements from transrectal ultrasonography by an automated and a manual technique. Br J Urol. 1996;78(2):219-23.
13. Roehrborn CG. Accurate determination of prostate size via digital rectal examination and transrectal ultrasound. Urology. 1998;51(4A Suppl):19-22.
14. Styles RA, Neal DE, Powell PH. Reproducibility of measurement of prostatic volume by ultrasound. Comparison of transrectal and transabdominal methods. European urology. 1988;14(4):266-9.
15. Huang Foen Chung JW, de Vries SH, Raaijmakers R, Postma R, Bosch JL, van Mastrigt R. Prostate volume ultrasonography: the influence of transabdominal versus transrectal approach, device type and operator. European urology. 2004;46(3):352-6.
16. Chen SS, Hong JG, Hsiao YJ, Chang LS. The correlation between clinical outcome and residual prostatic weight ratio after transurethral resection of the prostate for benign prostatic hyperplasia. BJU Int. 2000;85(1):79-82.
17. MC Songra RK. A study on the correlation between clinical outcome and residual prostatic weight ratio after transurethral resection of the prostate for benign prostatic hyperplasia. Indian Journal of urology. 2004;20(2):42-6.
18. AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations. J Urol. 2003;170(2 Pt 1):530-47.
19. Angalakuditi M, Seifert RF, Hayes RP, O'Leary MP, Viktrup L. Measurement properties of the benign prostatic hyperplasia impact index in tadalafil studies. Health and quality of life outcomes. 2010;8:131.
20. Barry MJ, Cockett AT, Holtgrewe HL, McConnell JD, Sihelnik SA, Winfield HN. Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia. The Journal of urology. 1993;150(2 Pt 1):351-8.
21. Boyle P, Robertson C, Mazzetta C, Keech M, Hobbs R, Fourcade R, et al. The relationship between lower urinary tract symptoms and health status: the UREPIK study. BJU international. 2003;92(6):575-80.
22. Ganpule AP, Desai MR, Desai MM, Wani KD, Bapat SD. Natural history of lower urinary tract symptoms: preliminary report from a community-based Indian study. BJU international. 2004;94(3):332-4.
23. O'Leary MP, Wei JT, Roehrborn CG, Miner M. Correlation of the International Prostate Symptom Score bother question with the Benign Prostatic Hyperplasia Impact Index in a clinical practice setting. BJU international.2008;101(12)1531-5.
Published
2016-03-05
How to Cite
GNYAWALI, Diwas; U, Sharma.
Correlation of prostate volume with ‘International Prostate Symptom Score’ and ‘Benign Prostatic Hyperplasia-Impact Index’ in benign prostatic hyperplasia.
J Soc Surg Nep, [S.l.], v. 17, n. 1, mar. 2016.
ISSN 2392-4772.
Available at: <https://www.jssn.org.np/index.php?journal=jssn&page=article&op=view&path%5B%5D=DOI%3A%20http%3A%2F%2Fdx.doi.org%2F10.3126%2Fjssn.v17i1.15174>. Date accessed: 02 may 2024.
Issue
Section
Original Article
Keywords
Benign prostatic hyperplasia; International Prostate Symptom Score; Benign Prostatic Hyperplasia Impact Index; Prostate weight
Copyright and Open Access Policy
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.
JSSN applies the Creative Commons Attribution (CC BY) license to all works we publish. Under the CC BY license, authors retain ownership of the copyright for their article, but authors allow anyone to download, reuse, reprint, distribute, and/or copy articles in JSSN, so long as the original authors and source are cited. No permission is required from the authors or the publishers.
Article by JSSN is licensed under a Creative Commons Attribution 4.0 International License.
Based on a work at http://www.jssn.org.np/index.php?journal=jssn.
